Jacqueline Coblentz
Overview
Explore the profile of Jacqueline Coblentz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bustamante P, Coblentz J, Mastromonaco C, Youhnovska E, Ito H, Proenca R, et al.
Melanoma Res
. 2024 Jun;
34(4):285-295.
PMID: 38847739
Uveal melanoma is the most common intraocular tumor in adults. Our group has previously developed a human uveal melanoma animal model; however, adverse effects caused by the immunosuppressive agent, cyclosporine...
2.
Mastromonaco C, Balazsi M, Coblentz J, Dias A, Zoroquiain P, Burnier Jr M
Indian J Ophthalmol
. 2022 May;
70(5):1617-1625.
PMID: 35502038
Purpose: Remnant lens epithelial cells (LECs) within the capsular bag (CB) undergo epithelial-to-mesenchymal transition (EMT) and acquire a myofibroblast phenotype, depositing extracellular matrix (ECM) components, leading to posterior capsular opacification...
3.
Bustamante P, Tsering T, Coblentz J, Mastromonaco C, Abdouh M, Fonseca C, et al.
J Exp Clin Cancer Res
. 2021 Jun;
40(1):196.
PMID: 34134723
Background: Uveal melanoma (UM) is the most common intraocular tumor in adults. Despite good primary tumor control, up to 50% of patients develop metastasis, which is lethal. UM often presents...
4.
Moreira-Neto C, Bergeron S, Coblentz J, Zoroquiain P, Maloney S, Mastromonaco C, et al.
Can J Ophthalmol
. 2019 Apr;
54(2):280-287.
PMID: 30975355
Objective: To develop a methodology to correlate optical coherence tomography (OCT) images and histopathological sections from the same eye. Part 1: To determine the best fixative for optimal OCT and...
5.
Mastromonaco C, Balazsi M, Zoroquiain P, Esposito E, Coblentz J, Logan P, et al.
Curr Eye Res
. 2018 Jul;
43(11):1362-1368.
PMID: 30009642
Materials And Methods: In total, 165 fixed eyes with intraocular lenses were sectioned to obtain a Miyake Apple view (MAV) image. The capsular bag (CB) with the in situ IOL...
6.
Coblentz J, Park J, Discepola G, Arthurs B, Burnier M
Can J Ophthalmol
. 2018 May;
53(3):e111-e113.
PMID: 29784173
No abstract available.
7.
Vila N, Coblentz J, Moreira-Neto C, Bravo-Filho V, Zoroquiain P, Burnier Jr M
Ophthalmic Res
. 2016 Oct;
57(1):48-53.
PMID: 27744444
Purpose: To determine whether pretreatment of retinal pigmented epithelial (RPE) cells with lutein can affect the response of cells to bevacizumab therapy. Methods: One human RPE cell line (ARPE-19) was...
8.
Motta M, Fortes Filho J, Coblentz J, Fiorot C
Clin Ophthalmol
. 2012 Jan;
5:1783-7.
PMID: 22267912
Background: The influence of multiple gestation on the occurrence of retinopathy of prematurity (ROP) is still not completely understood. Objectives: To verify the incidence of any stage of ROP and...
9.
Coblentz J, Motta M, Fernandes B, Burnier Jr M, Vianna R
Curr Eye Res
. 2009 Dec;
34(11):925-7.
PMID: 19958108
Background/aims: To evaluate and compare obtained mydriasis with phenylephrine 10% associated with tropicamide 1% in type 2 diabetics and non-diabetic patients. Methods: A total of 50 patients (100 eyes) scheduled...
10.
Motta M, Coblentz J, Fernandes B, Burnier Jr M
Ophthalmic Res
. 2009 May;
42(2):87-9.
PMID: 19478547
Background/aims: To evaluate and compare cardiovascular effects (blood pressure and heart rate) of phenylephrine 2.5% versus phenylephrine 10%, and compare pupil diameter before and after instillation of eyedrops. Methods: A...